DEF: Butterfly Network 2026 Annual Meeting Proxy Statement

Butterfly Network, Inc. has issued its 2026 proxy statement detailing the upcoming annual meeting of stockholders to be held virtually on June 18, 2026.

Summary

• The 2026 annual meeting of stockholders is scheduled for June 18, 2026, at 11:00 a.m. ET via a virtual-only format.
• Stockholders will vote on the election of seven directors, the ratification of Deloitte & Touche LLP as the independent auditor for 2026, and a non-binding advisory vote on executive compensation.
• The company remains a 'controlled company' due to Jonathan M. Rothberg, Ph.D. holding a majority of the voting power.
• The company reported 261,640,906 shares of common stock outstanding as of the April 21, 2026 record date.
• The company successfully launched Compass 2.0 and moved the P5 generation chip into production during 2025.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a standard, neutral proxy filing. While the company shows progress in operational milestones and product development, the continued net losses and controlled company status keep the sentiment balanced.

Positives

• Successful launch of Compass 2.0 enterprise software.
• Achievement of key operational milestones including signing two additional enterprise customers.
• Successful transition of the P5 generation chip into production.
• Strong governance structure with independent chairs for all key board committees.

Negatives

• The company continues to report net losses ($77.1 million for 2025).
• The company remains a 'controlled company' until at least February 2028, limiting certain shareholder protections.
• None of the directors attended the 2025 annual meeting of stockholders.

Risks

• Dependence on the controlling shareholder, Jonathan M. Rothberg, Ph.D., for voting control.
• Risks associated with the ability to grow and manage growth profitably.
• Potential for future regulatory changes or failure to maintain existing regulatory approvals.
• Intense competition in the medical imaging and AI-enabled analytics market.
• Cybersecurity threats to customer and company data.

Future Outlook

The company focuses on scaling its enterprise software (Compass), expanding its customer base, and continuing innovation in AI-enabled ultrasound technology, while managing capital requirements and seeking profitable growth.

Management Comments

• Management emphasizes the importance of the virtual meeting format for increasing global stockholder participation and efficiency.
• The board expresses confidence in the current leadership structure, noting that a combined CEO/Chairman role promotes clear leadership and strategic execution.

Industry Context

StockSavvy.ai notes that Butterfly Network continues to navigate the competitive landscape of point-of-care ultrasound (POCUS) and AI-integrated medical devices, where incumbents like GE Healthcare and Philips remain dominant. The company's shift toward enterprise software (Compass) reflects a broader industry trend of moving from hardware-only sales to recurring revenue models.

Comparison to Industry Standards

• The company's reliance on a dual-class share structure is common among founder-led technology companies but is increasingly scrutinized by institutional investors.
• The use of a virtual-only meeting format is consistent with post-pandemic trends among mid-cap technology firms to reduce costs and increase accessibility.
• The executive compensation structure, including performance-based RSUs tied to stock price hurdles, aligns with standard practices for high-growth medical technology companies.

Management Changes

Corporate Governance

Legal Proceedings

• None disclosed in the filing.

Related Party Transactions

• Technology and Services Exchange Agreement with entities controlled by the Rothbergs.
• Advisory Agreement with Jonathan M. Rothberg, Ph.D. for strategic consulting services.

Stakeholder Impact

• Shareholders are encouraged to vote on key governance and compensation proposals.
• Employees and directors are subject to updated insider trading and compensation recovery policies.

Next Steps

• Hold the 2026 Annual Meeting of Stockholders on June 18, 2026.
• File preliminary/final voting results in a Form 8-K within four business days of the meeting.
• Continue the transition of the Chief Financial Officer role and advisory services.

Key Dates

Recommendation

The filing is a standard proxy statement for an annual meeting. It does not contain material financial surprises or strategic pivots that would warrant a change in investment stance, though the company's path to profitability remains a key long-term monitorable.

Keywords

Butterfly Network, BFLY, Proxy Statement, Medical Imaging, Corporate Governance, Executive Compensation, Annual Meeting